Abiopharma

🔍 BROWN DAVID A (Director)

Company: Hamilton Insurance Group, Ltd. (HG)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 4,929 shares of Class B Common Shares (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 110,308.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Class B Common Shares (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: By Leyton Ltd. | shares_owned_after: 500,000.00 | Footnotes: F3

Footnotes:

• F1: Represents an annual grant of restricted stock units ("RSUs") awarded to the reporting person pursuant to the Hamilton Insurance Group, Ltd. (the "Company") Non-Employee Director Compensation Program. The number of RSUs was determined based on a target grant value of $150,000 and the closing price of the Company's common shares on May 5, 2026, which was $30.43 per share. The RSUs cliff vest on the earlier of the one-year anniversary of the grant date or the date of the subsequent annual general meeting.
• F2: Includes restricted stock units.
• F3: An investment holding company held by Thelwall Trust, a family trust established for the benefit of the reporting person and his family.